+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • AbbVie Inc
  • Astellas Pharma Inc
  • Daiichi Sankyo Co Ltd
  • Gilead Sciences Inc
  • Johnson & Johnson
  • Novartis AG
  • MORE
Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Theravance Biopharma Inc (Theravance Biopharma) is a diversified biopharmaceutical company that focuses on the discovery, development, and marketing of organ-selective medicines for the treatment of inflammation and immune system disorders. The company is investigating its pipeline candidates for the treatment of asthma; neurogenic orthostatic hypotension (nOH); gastrointestinal motility disorders; ulcerative colitis; heart failure; chronic kidney disease (CKD); Crohn’s disease; gastroparesis; myelofibrosis; concurrent bacteremia; rheumatoid arthritis; and blood pressure. Its Yupelritm (revefenacin) obtained the US FDA approval for the treatment of chronic obstructive pulmonary disease (COPD) in the US. The company has subsidiaries in the US, Ireland and the UK. Theravance Biopharma is headquartered in South San Francisco, California, the US.

Theravance Biopharma Inc Key Recent Developments

Feb 26, 2019 Theravance Biopharma announces fourth quarter and full year 2018 financial results
Jan 07, 2019 Theravance Biopharma Announces Alignment of Workforce with Focus on Key Strategic Priorities
Dec 04, 2018 Theravance Biopharma to highlight innovative early research and clinical development at R&D day on December 12 in New York
Nov 08, 2018 Theravance Biopharma Announces First Subject Dosed in Phase 1 Clinical Trial of TD-8236, a Novel Inhaled pan-JAK Inhibitor

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbbVie Inc
  • Astellas Pharma Inc
  • Daiichi Sankyo Co Ltd
  • Gilead Sciences Inc
  • Johnson & Johnson
  • Novartis AG
  • MORE
Section 1 - About the Company
  • Theravance Biopharma Inc - Key Facts
  • Theravance Biopharma Inc - Key Employees
  • Theravance Biopharma Inc - Key Employee Biographies
  • Theravance Biopharma Inc - Major Products and Services
  • Theravance Biopharma Inc - History
  • Theravance Biopharma Inc - Company Statement
  • Theravance Biopharma Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Theravance Biopharma Inc - Business Description
  • R&D Overview
  • Theravance Biopharma Inc - Corporate Strategy
  • Theravance Biopharma Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Theravance Biopharma Inc - Strengths
  • Theravance Biopharma Inc - Weaknesses
  • Theravance Biopharma Inc - Opportunities
  • Theravance Biopharma Inc - Threats
  • Theravance Biopharma Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Theravance Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Theravance Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Theravance Biopharma Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Feb 26, 2019: Theravance Biopharma announces fourth quarter and full year 2018 financial results
  • Jan 07, 2019: Theravance Biopharma Announces Alignment of Workforce with Focus on Key Strategic Priorities
  • Dec 04, 2018: Theravance Biopharma to highlight innovative early research and clinical development at R&D day on December 12 in New York
  • Nov 08, 2018: Theravance Biopharma Announces First Subject Dosed in Phase 1 Clinical Trial of TD-8236, a Novel Inhaled pan-JAK Inhibitor
  • Nov 07, 2018: Theravance Biopharma to Present at the Credit Suisse 27th Annual Healthcare Conference
  • Nov 06, 2018: Theravance Biopharma reports third quarter 2018 financial results and provides business update
  • Oct 08, 2018: Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV (telavancin) at IDWeek
  • Sep 17, 2018: Oragenics, Inc. to Present Data from Its Lantibiotics Program at the Boulder Peptide Symposium Monday, September 24, 2018[Newswire : Healthcare-BW]
  • Sep 17, 2018: AmpliPhi Biosciences Announces Positive FDA Feedback for its Clinical Stage Bacteriophage Product Candidate AB-SA01[Newswire : Healthcare-BW]
  • Sep 17, 2018: Delos Adds Technology Business Leader Anthony Antolino as Chief Commercial Officer[Newswire : Healthcare-BW]
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Theravance Biopharma Inc, Key Facts
  • Theravance Biopharma Inc, Key Employees
  • Theravance Biopharma Inc, Key Employee Biographies
  • Theravance Biopharma Inc, Major Products and Services
  • Theravance Biopharma Inc, History
  • Theravance Biopharma Inc, Subsidiaries
  • Theravance Biopharma Inc, Key Competitors
  • Theravance Biopharma Inc, Ratios based on current share price
  • Theravance Biopharma Inc, Annual Ratios
  • Theravance Biopharma Inc, Annual Ratios (Cont...1)
  • Theravance Biopharma Inc, Interim Ratios
  • Theravance Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Theravance Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Theravance Biopharma Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Theravance Biopharma Inc, Performance Chart (2014 - 2018)
  • Theravance Biopharma Inc, Ratio Charts
  • Theravance Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Theravance Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Takeda Pharmaceutical Co Ltd
  • Shire Plc
  • Sanofi
  • Pfizer Inc
  • Novo Nordisk AS
  • Novartis AG
  • Merck & Co Inc
  • Johnson & Johnson
  • GlaxoSmithKline Plc
  • Gilead Sciences Inc
  • F. Hoffmann-La Roche Ltd
  • Daiichi Sankyo Co Ltd
  • Bristol-Myers Squibb Co
  • Astellas Pharma Inc
  • Amgen Inc
  • AbbVie Inc
Note: Product cover images may vary from those shown
Adroll
adroll